CBLIF
gene geneOn this page
Also known as TCN3IFIFMHINF
Summary
CBLIF (cobalamin binding intrinsic factor, HGNC:4268) is a protein-coding gene on chromosome 11q12.1, encoding Cobalamin binding intrinsic factor (P27352). Promotes absorption of the essential vitamin cobalamin (Cbl) in the ileum.
This gene is a member of the cobalamin transport protein family. It encodes a glycoprotein secreted by parietal cells of the gastric mucosa and is required for adequate absorption of vitamin B12. Vitamin B12 is necessary for erythrocyte maturation and mutations in this gene may lead to congenital pernicious anemia.
Source: NCBI Gene 2694 — RefSeq curated summary.
At a glance
- Gene–disease (curated): hereditary intrinsic factor deficiency (Strong, GenCC)
- Clinical variants (ClinVar): 176 total — 9 pathogenic, 7 likely-pathogenic
- Phenotypes (HPO): 26
- MANE Select transcript:
NM_005142
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:4268 |
| Approved symbol | CBLIF |
| Name | cobalamin binding intrinsic factor |
| Location | 11q12.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TCN3, IF, IFMH, INF |
| Ensembl gene | ENSG00000134812 |
| Ensembl biotype | protein_coding |
| OMIM | 609342 |
| Entrez | 2694 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 3 retained_intron, 1 protein_coding, 1 nonsense_mediated_decay
ENST00000257248, ENST00000525058, ENST00000532070, ENST00000533067, ENST00000533847
RefSeq mRNA: 1 — MANE Select: NM_005142
NM_005142
CCDS: CCDS7977
Canonical transcript exons
ENST00000257248 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001170003 | 59845375 | 59845499 |
| ENSE00002164105 | 59829273 | 59829545 |
| ENSE00003511670 | 59837174 | 59837351 |
| ENSE00003534224 | 59831678 | 59831796 |
| ENSE00003541413 | 59843879 | 59844055 |
| ENSE00003566775 | 59843028 | 59843141 |
| ENSE00003614041 | 59835808 | 59836009 |
| ENSE00003671074 | 59842443 | 59842583 |
| ENSE00003678028 | 59841143 | 59841324 |
Expression profiles
Bgee: expression breadth ubiquitous, 141 present calls, max score 99.65.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.6098 / max 1088.2645, expressed in 7 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 119883 | 0.6098 | 7 |
Top tissues by expression
281 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cardia of stomach | UBERON:0001162 | 99.65 | gold quality |
| pylorus | UBERON:0001166 | 98.03 | gold quality |
| body of stomach | UBERON:0001161 | 90.18 | gold quality |
| stomach | UBERON:0000945 | 89.77 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 89.54 | gold quality |
| fundus of stomach | UBERON:0001160 | 87.26 | gold quality |
| buccal mucosa cell | CL:0002336 | 72.78 | silver quality |
| diaphragm | UBERON:0001103 | 67.09 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 66.35 | gold quality |
| pancreatic ductal cell | CL:0002079 | 64.70 | silver quality |
| cervix squamous epithelium | UBERON:0006922 | 63.21 | gold quality |
| olfactory bulb | UBERON:0002264 | 60.49 | gold quality |
| type B pancreatic cell | CL:0000169 | 60.27 | gold quality |
| heart right ventricle | UBERON:0002080 | 59.63 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 59.58 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 58.71 | gold quality |
| right lung | UBERON:0002167 | 58.18 | gold quality |
| hair follicle | UBERON:0002073 | 57.19 | gold quality |
| decidua | UBERON:0002450 | 56.92 | gold quality |
| ileal mucosa | UBERON:0000331 | 56.30 | silver quality |
| myocardium | UBERON:0002349 | 55.22 | gold quality |
| thymus | UBERON:0002370 | 54.16 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 53.64 | gold quality |
| endocervix | UBERON:0000458 | 53.49 | gold quality |
| rectum | UBERON:0001052 | 53.17 | gold quality |
| blood | UBERON:0000178 | 52.68 | gold quality |
| cranial nerve II | UBERON:0000941 | 52.59 | silver quality |
| cervix epithelium | UBERON:0004801 | 52.57 | gold quality |
| quadriceps femoris | UBERON:0001377 | 52.17 | gold quality |
| uterine cervix | UBERON:0000002 | 51.83 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.91 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): CREB1, KLF10, NEUROG1, USF1, USF2
miRNA regulators (miRDB)
28 targeting CBLIF, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-507 | 99.97 | 70.11 | 1915 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-450B-5P | 99.92 | 71.48 | 3175 |
| HSA-MIR-129-5P | 99.88 | 70.26 | 3273 |
| HSA-MIR-448 | 99.79 | 72.37 | 2103 |
| HSA-MIR-3680-3P | 99.75 | 72.51 | 3095 |
| HSA-MIR-2681-5P | 99.75 | 67.64 | 1655 |
| HSA-MIR-3616-5P | 99.55 | 67.02 | 989 |
| HSA-MIR-573 | 99.55 | 67.44 | 955 |
| HSA-MIR-12131 | 99.48 | 68.72 | 1673 |
| HSA-MIR-1911-3P | 99.15 | 66.17 | 528 |
| HSA-MIR-1253 | 99.12 | 67.08 | 1688 |
| HSA-MIR-4795-5P | 99.11 | 66.90 | 876 |
| HSA-MIR-153-3P | 98.96 | 72.51 | 1644 |
| HSA-MIR-4716-5P | 98.82 | 68.57 | 1168 |
| HSA-MIR-937-5P | 97.43 | 68.39 | 667 |
| HSA-MIR-3121-5P | 97.30 | 66.62 | 1146 |
| HSA-MIR-620 | 96.94 | 66.79 | 888 |
| HSA-MIR-1270 | 96.94 | 66.65 | 931 |
| HSA-MIR-5702 | 96.68 | 68.21 | 958 |
| HSA-MIR-4790-5P | 96.67 | 67.45 | 167 |
| HSA-MIR-597-3P | 96.46 | 68.03 | 1035 |
| HSA-MIR-6753-5P | 94.70 | 64.08 | 470 |
| HSA-MIR-3672 | 94.46 | 65.67 | 646 |
| HSA-MIR-6864-3P | 94.46 | 65.97 | 625 |
Literature-anchored findings (GeneRIF, showing 12)
- A polymorphism in the gastric intrinsic factor gene is associated with congenital intrinsic factor deficiency. (PMID:14695536)
- The parameters obtained for ligand and receptor binding in this study indicate that both full-length 50-kDA intrinsic factor and its 30-kDa and 20-kDa fragments may be involved in assimilation of cobalamin. (PMID:15736970)
- possible basis for the lack of interchangeability of human and rat IF receptors is presented (PMID:17954916)
- The Q5R mutation of the intrinsic factor gene predisposes to adult-onset pernicious anemia & other causes of low vitamin B12. In this mutation, intrinsic factor secretion is preserved but B12 absorption may be impaired. (PMID:18338170)
- a specific GIF mutation to be responsible for all Juvenile cobalamin deficiency cases of West-African origin so far was identified (PMID:19036097)
- crystal structure of the complex between IF-Cbl and the cubilin IF-Cbl-binding-region (CUB(5-8)) determined at 3.3 A resolution (PMID:20237569)
- Acute lymphoblastic leukemia and vitamin B12 deficiency secondary to a gastric intrinsic factor gene mutation (PMID:22556038)
- Our genetic screening of 154 families of patients with inherited cobalamin malabsorption revealed population-specific mutations, mutational hotspots, and functionally distinct regions in the three causal genes: CUBN, AMN, and GIF. (PMID:22929189)
- study reports that FUT2 secretor variant influences GIF secretion in B12 deficient cases bearing GIF heterozygous mutations, in absence of H. pylori related gastritis (PMID:23402911)
- the present findings reveal that High-altitude polycythemia -induced gastric mucosal lesion inspires the protection responses by up-regulating APOA4 and APOC3, and down-regulating GIF. (PMID:26485402)
- The gastric intrinsic factor (GIF) 290C heterozygous/fucosyltransferase 2 (secretor status included) protein (FUT2) rs601338 secretor variant combined genotype was indicated in 6 of the 37 neural tube defects (NTDs) fetuses. (PMID:28742214)
- Pancytopenia and megaloblastic erythropoiesis reveal a novel GIF mutation. (PMID:29368379)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Cblif | ENSMUSG00000024682 |
| rattus_norvegicus | Cblif | ENSRNOG00000021001 |
| drosophila_melanogaster | CG3556 | FBGN0029708 |
Paralogs (2): TCN1 (ENSG00000134827), TCN2 (ENSG00000185339)
Protein
Protein identifiers
Cobalamin binding intrinsic factor — P27352 (reviewed: P27352)
Alternative names: Gastric intrinsic factor, Intrinsic factor
All UniProt accessions (2): P27352, E9PM21
UniProt curated annotations — full annotation on UniProt →
Function. Promotes absorption of the essential vitamin cobalamin (Cbl) in the ileum. After interaction with CUBN, the CBLIF-cobalamin complex is internalized via receptor-mediated endocytosis.
Subunit / interactions. Interacts with CUBN (via CUB domains).
Subcellular location. Secreted.
Tissue specificity. Gastric mucosa.
Disease relevance. Hereditary intrinsic factor deficiency (IFD) [MIM:261000] Autosomal recessive disorder characterized by megaloblastic anemia. The disease is caused by variants affecting the gene represented in this entry.
Similarity. Belongs to the eukaryotic cobalamin transport proteins family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P27352-1 | 1 | yes |
| P27352-2 | 2 |
RefSeq proteins (1): NP_005133* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002157 | Cbl-bd_prot | Family |
| IPR051588 | Cobalamin_Transport | Family |
Pfam: PF01122
UniProt features (53 total): helix 18, strand 8, binding site 5, glycosylation site 4, sequence variant 4, sequence conflict 4, disulfide bond 3, turn 3, signal peptide 1, chain 1, splice variant 1, modified residue 1
Structure
Experimental structures (PDB)
2 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 2PMV | X-RAY DIFFRACTION | 2.6 |
| 3KQ4 | X-RAY DIFFRACTION | 3.3 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P27352-F1 | 90.69 | 0.83 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (5): 171; 222; 270; 365–370; 386–395
Post-translational modifications (1): 191
Disulfide bonds (3): 26–246, 103–288, 143–182
Glycosylation sites (4): 334, 413, 311, 330
Function
Pathways and Gene Ontology
Reactome pathways
4 pathways
| ID | Pathway |
|---|---|
| R-HSA-3359457 | Defective CBLIF causes IFD |
| R-HSA-3359462 | Defective AMN causes MGA1 |
| R-HSA-3359463 | Defective CUBN causes MGA1 |
| R-HSA-9758881 | Uptake of dietary cobalamins into enterocytes |
MSigDB gene sets: 155 (showing top):
GOBP_TRANSITION_METAL_ION_TRANSPORT, GOBP_MONOATOMIC_CATION_TRANSPORT, GOBP_VITAMIN_TRANSPORT, MORF_EPHA7, MORF_RAB3A, GOCC_APICAL_PLASMA_MEMBRANE, LEE_CALORIE_RESTRICTION_NEOCORTEX_UP, MORF_WNT1, VECCHI_GASTRIC_CANCER_EARLY_DN, MCCLUNG_COCAIN_REWARD_4WK, MORF_IL9, GOBP_TRANSMEMBRANE_TRANSPORT, MORF_DCC, AP1FJ_Q2, GOCC_LYSOSOMAL_LUMEN
GO Biological Process (3): cobalt ion transport (GO:0006824), cobalamin transport (GO:0015889), monoatomic ion transport (GO:0006811)
GO Molecular Function (4): cobalamin binding (GO:0031419), molecular carrier activity (GO:0140104), cargo receptor ligand activity (GO:0140355), protein binding (GO:0005515)
GO Cellular Component (6): extracellular region (GO:0005576), obsolete extracellular space (GO:0005615), endosome (GO:0005768), microvillus (GO:0005902), apical plasma membrane (GO:0016324), lysosomal lumen (GO:0043202)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Defects in cobalamin (B12) metabolism | 3 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 2 |
| transition metal ion transport | 1 |
| monoatomic cation transmembrane transport | 1 |
| vitamin transport | 1 |
| nitrogen compound transport | 1 |
| transport | 1 |
| vitamin binding | 1 |
| tetrapyrrole binding | 1 |
| heterocyclic compound binding | 1 |
| molecular_function | 1 |
| protein binding | 1 |
| cellular anatomical structure | 1 |
| endomembrane system | 1 |
| cytoplasmic vesicle | 1 |
| actin filament bundle | 1 |
| actin-based cell projection | 1 |
| apical part of cell | 1 |
| plasma membrane region | 1 |
| lysosome | 1 |
| vacuolar lumen | 1 |
Protein interactions and networks
STRING
448 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CBLIF | CUBN | O60494 | 984 |
| CBLIF | AMN | Q9BXJ7 | 899 |
| CBLIF | CBL | P22681 | 815 |
| CBLIF | LRP2 | P98164 | 793 |
| CBLIF | C1R | P00736 | 711 |
| CBLIF | C1S | P09871 | 694 |
| CBLIF | ATP4B | P51164 | 676 |
| CBLIF | LDLRAP1 | Q5SW96 | 639 |
| CBLIF | TFF2 | Q03403 | 633 |
| CBLIF | BMP1 | P13497 | 592 |
| CBLIF | GAST | P01350 | 567 |
| CBLIF | CD320 | Q9NPF0 | 560 |
| CBLIF | MUC6 | Q6W4X9 | 531 |
| CBLIF | LTF | P02788 | 524 |
| CBLIF | GC | P02774 | 515 |
IntAct
29 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CBLIF | SLC7A14 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CBLIF | FFAR2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CBLIF | SLC13A4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CBLIF | TMEM237 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SLC22A23 | CBLIF | psi-mi:“MI:0915”(physical association) | 0.560 |
| CBLIF | SLC7A1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FFAR2 | CBLIF | psi-mi:“MI:0915”(physical association) | 0.560 |
| CBLIF | CUBN | psi-mi:“MI:0407”(direct interaction) | 0.560 |
| ZNF354C | LRP4 | psi-mi:“MI:0914”(association) | 0.530 |
| SLC5A9 | CD63 | psi-mi:“MI:0914”(association) | 0.530 |
| CBLIF | CBLIF | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| CBLIF | HSPA8 | psi-mi:“MI:0915”(physical association) | 0.400 |
| GALNT5 | CBLIF | psi-mi:“MI:0915”(physical association) | 0.400 |
| CBLIF | FBXO2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| EBNA1 | IGF2BP3 | psi-mi:“MI:0914”(association) | 0.350 |
| SPAST | CBLIF | psi-mi:“MI:0914”(association) | 0.350 |
| CBLIF | SLC13A4 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CBLIF | TMEM237 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CBLIF | SLC7A1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CBLIF | SLC22A23 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (18): FBXO2 (Affinity Capture-MS), GIF (Affinity Capture-MS), GIF (Two-hybrid), GIF (Two-hybrid), SLC22A23 (Two-hybrid), SLC7A1 (Two-hybrid), TMEM237 (Two-hybrid), SLC13A4 (Two-hybrid), GIF (Proximity Label-MS), GIF (Reconstituted Complex), FBXO2 (Affinity Capture-MS), GIF (Affinity Capture-MS), GIF (Affinity Capture-MS), GIF (Affinity Capture-MS), GIF (Affinity Capture-MS)
ESM2 similar proteins: A2RT67, A4D0V7, A4FV27, A6NFY4, D2XPP7, D3Z2R5, O18638, O70367, O75129, O75829, O77770, P0CG01, P17267, P17404, P20362, P24405, P27352, P40682, P45641, P52787, P54863, P79894, Q2MV58, Q3U128, Q52LC2, Q5PPI4, Q5R2I8, Q5R2J4, Q5RBY5, Q62522, Q66KI8, Q6DF34, Q6E211, Q6PGD0, Q6Q2W4, Q6UW56, Q7Z7H3, Q8CB65, Q8J025, Q95LL7
Diamond homologs: P17267, P20061, P27352, P52787, Q5XWD5, P17630, P20062, Q5REL7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
176 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 9 |
| Likely pathogenic | 7 |
| Uncertain significance | 77 |
| Likely benign | 52 |
| Benign | 15 |
Top pathogenic / likely-pathogenic (16)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1745 | NM_005142.3(CBLIF):c.80-1G>A | Pathogenic |
| 1747 | NM_005142.3(CBLIF):c.161del (p.Asn54fs) | Pathogenic |
| 1748 | NM_005142.3(CBLIF):c.1175dup (p.Thr393fs) | Pathogenic |
| 208191 | NM_005142.3(CBLIF):c.346C>T (p.Gln116Ter) | Pathogenic |
| 2903417 | NM_005142.3(CBLIF):c.310C>T (p.Arg104Ter) | Pathogenic |
| 3721037 | NM_005142.3(CBLIF):c.659T>C (p.Ile220Thr) | Pathogenic |
| 439755 | NM_005142.3(CBLIF):c.79+1G>A | Pathogenic |
| 4749260 | NM_005142.3(CBLIF):c.52_56del (p.Thr18fs) | Pathogenic |
| 566919 | NM_005142.3(CBLIF):c.183_186del (p.Met61fs) | Pathogenic |
| 1746 | NM_005142.3(CBLIF):c.137C>T (p.Ser46Leu) | Likely pathogenic |
| 1969715 | NM_005142.3(CBLIF):c.370+83_426del | Likely pathogenic |
| 2425302 | NC_000011.9:g.(?59603261)(59604844_?)dup | Likely pathogenic |
| 2431712 | NM_005142.3(CBLIF):c.370+1G>C | Likely pathogenic |
| 3362465 | NM_005142.3(CBLIF):c.395_396delinsAA (p.Phe132Ter) | Likely pathogenic |
| 3766532 | NM_005142.3(CBLIF):c.67_68del (p.Gln23fs) | Likely pathogenic |
| 830018 | NM_005142.3(CBLIF):c.661G>A (p.Gly221Arg) | Likely pathogenic |
SpliceAI
1202 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:59837348:GAGC:G | acceptor_gain | 1.0000 |
| 11:59837349:AGCC:A | acceptor_loss | 1.0000 |
| 11:59837350:GC:G | acceptor_gain | 1.0000 |
| 11:59837351:CC:C | acceptor_gain | 1.0000 |
| 11:59837352:CTGGG:C | acceptor_loss | 1.0000 |
| 11:59837353:T:A | acceptor_loss | 1.0000 |
| 11:59841325:C:CC | acceptor_gain | 1.0000 |
| 11:59842587:C:CT | acceptor_gain | 1.0000 |
| 11:59842588:G:T | acceptor_gain | 1.0000 |
| 11:59843008:C:CA | donor_gain | 1.0000 |
| 11:59843026:A:AC | donor_gain | 1.0000 |
| 11:59843027:C:CC | donor_gain | 1.0000 |
| 11:59843873:TCTCA:T | donor_loss | 1.0000 |
| 11:59843874:CTCA:C | donor_loss | 1.0000 |
| 11:59843875:TCACC:T | donor_loss | 1.0000 |
| 11:59843876:CACC:C | donor_loss | 1.0000 |
| 11:59843877:A:AC | donor_gain | 1.0000 |
| 11:59843877:A:C | donor_loss | 1.0000 |
| 11:59843878:C:CC | donor_gain | 1.0000 |
| 11:59844053:CGG:C | acceptor_gain | 1.0000 |
| 11:59845374:CAG:C | donor_gain | 1.0000 |
| 11:59829543:CCC:C | acceptor_gain | 0.9900 |
| 11:59829543:CCCCT:C | acceptor_loss | 0.9900 |
| 11:59829544:CCC:C | acceptor_gain | 0.9900 |
| 11:59829545:CCTG:C | acceptor_loss | 0.9900 |
| 11:59829546:CT:C | acceptor_loss | 0.9900 |
| 11:59829547:T:A | acceptor_loss | 0.9900 |
| 11:59831797:C:CC | acceptor_gain | 0.9900 |
| 11:59835806:A:AC | donor_gain | 0.9900 |
| 11:59835807:C:CC | donor_gain | 0.9900 |
AlphaMissense
2744 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:59831712:C:A | W386C | 0.991 |
| 11:59831712:C:G | W386C | 0.991 |
| 11:59831714:A:G | W386R | 0.990 |
| 11:59831714:A:T | W386R | 0.990 |
| 11:59829504:C:G | A412P | 0.986 |
| 11:59829503:G:T | A412D | 0.982 |
| 11:59835833:C:G | A350P | 0.978 |
| 11:59841297:A:G | L180P | 0.978 |
| 11:59842546:A:C | S136R | 0.978 |
| 11:59842546:A:T | S136R | 0.978 |
| 11:59842548:T:G | S136R | 0.978 |
| 11:59843106:C:G | A98P | 0.976 |
| 11:59837313:C:A | W244C | 0.974 |
| 11:59837313:C:G | W244C | 0.974 |
| 11:59831713:C:G | W386S | 0.972 |
| 11:59841292:A:G | C182R | 0.971 |
| 11:59837230:A:G | L272P | 0.969 |
| 11:59843947:A:G | L63P | 0.969 |
| 11:59841290:A:C | C182W | 0.968 |
| 11:59831793:A:C | F359L | 0.967 |
| 11:59831793:A:T | F359L | 0.967 |
| 11:59831795:A:G | F359L | 0.967 |
| 11:59842525:G:C | C143W | 0.967 |
| 11:59835810:G:C | F357L | 0.966 |
| 11:59835810:G:T | F357L | 0.966 |
| 11:59835812:A:G | F357L | 0.966 |
| 11:59835935:A:C | Y316D | 0.966 |
| 11:59842527:A:G | C143R | 0.966 |
| 11:59831761:A:T | V370D | 0.965 |
| 11:59837239:G:T | A269D | 0.965 |
dbSNP variants (sampled 300 via entrez): RS1000067116 (11:59831417 T>C), RS1000553130 (11:59834539 C>T), RS1000716897 (11:59828830 T>C), RS1000966650 (11:59847443 A>T), RS1000985388 (11:59840989 A>C,G), RS1001016630 (11:59840536 A>C), RS1001310716 (11:59847077 A>G), RS1001333685 (11:59837700 T>C), RS1001338574 (11:59831146 T>C), RS1001461489 (11:59844800 T>C), RS1001489258 (11:59834249 T>A,C), RS1001720440 (11:59835452 A>G), RS1001842727 (11:59830706 T>C), RS1001924823 (11:59833933 A>G), RS1001968500 (11:59841950 C>G,T)
Disease associations
OMIM: gene MIM:609342 | disease phenotypes: MIM:261000
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| hereditary intrinsic factor deficiency | Strong | Autosomal recessive |
Mondo (1): hereditary intrinsic factor deficiency (MONDO:0009852)
Orphanet (1): Congenital intrinsic factor deficiency (Orphanet:332)
HPO phenotypes
26 total (26 of 26 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000726 | Dementia |
| HP:0001328 | Specific learning disability |
| HP:0001510 | Growth delay |
| HP:0001889 | Megaloblastic anemia |
| HP:0002160 | Hyperhomocystinemia |
| HP:0002315 | Headache |
| HP:0002719 | Recurrent infections |
| HP:0002912 | Methylmalonic acidemia |
| HP:0003401 | Paresthesia |
| HP:0003474 | Somatic sensory dysfunction |
| HP:0003621 | Juvenile onset |
| HP:0005219 | Absence of intrinsic factor |
| HP:0005518 | Increased mean corpuscular volume |
| HP:0006827 | Atrophy of the spinal cord |
| HP:0009830 | Peripheral neuropathy |
| HP:0011463 | Childhood onset |
| HP:0012120 | Methylmalonic aciduria |
| HP:0020181 | Reduced haptoglobin level |
| HP:0025406 | Asthenia |
| HP:0025435 | Increased circulating lactate dehydrogenase concentration |
| HP:0031965 | Increased RBC distribution width |
| HP:0100502 | Decreased circulating vitamin B12 concentration |
| HP:0200118 | Malabsorption of Vitamin B12 |
| HP:0200143 | Megaloblastic erythroid hyperplasia |
| HP:6000344 | Anti-intrinsic factor antibody positivity |
GWAS associations
0 associations (top):
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| C563242 | Intrinsic Factor Deficiency (supp.) |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
| perfluorooctane sulfonic acid | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cadmium | decreases expression | 1 |
| Free Radicals | affects metabolic processing | 1 |
| Tetradecanoylphorbol Acetate | affects cotreatment, affects expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tretinoin | affects expression | 1 |
| Zinc | affects cotreatment, affects expression | 1 |
| Hydroxyl Radical | affects metabolic processing | 1 |
Cellosaurus cell lines
1 cell lines: 1 finite cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B3YS | WG2436 | Finite cell line | Female |
Clinical trials (associated diseases)
1 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT03655223 | Not specified | ENROLLING_BY_INVITATION | Early Check: Expanded Screening in Newborns |
Related Atlas pages
- Associated diseases: hereditary intrinsic factor deficiency
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): hereditary intrinsic factor deficiency